GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » EV-to-EBIT

Cybin (CYBN) EV-to-EBIT

: -5.18 (As of Today)
View and export this data going back to 2020. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cybin's Enterprise Value is $258.79 Mil. Cybin's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-50.00 Mil. Therefore, Cybin's EV-to-EBIT for today is -5.18.

The historical rank and industry rank for Cybin's EV-to-EBIT or its related term are showing as below:

CYBN' s EV-to-EBIT Range Over the Past 10 Years
Min: -16.78   Med: -1.63   Max: 0.52
Current: -5.26

During the past 4 years, the highest EV-to-EBIT of Cybin was 0.52. The lowest was -16.78. And the median was -1.63.

CYBN's EV-to-EBIT is ranked worse than
100% of 440 companies
in the Biotechnology industry
Industry Median: 8.685 vs CYBN: -5.26

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cybin's Enterprise Value for the quarter that ended in Dec. 2023 was $137.84 Mil. Cybin's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-50.00 Mil. Cybin's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -36.27%.

Cybin EV-to-EBIT Historical Data

The historical data trend for Cybin's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cybin Annual Data
Trend Mar20 Mar21 Mar22 Mar23
EV-to-EBIT
- -4.61 -1.81 -1.69

Cybin Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.04 -1.69 -1.87 -3.16 -2.63
Competitive Comparison

For the Biotechnology subindustry, Cybin's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cybin EV-to-EBIT Distribution

For the Biotechnology industry and Healthcare sector, Cybin's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cybin's EV-to-EBIT falls into.


Cybin EV-to-EBIT Calculation

Cybin's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=258.786/-50.002
=-5.18

Cybin's current Enterprise Value is $258.79 Mil.
Cybin's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-50.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cybin  (AMEX:CYBN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cybin's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-50.002/137.84481
=-36.27 %

Cybin's Enterprise Value for the quarter that ended in Dec. 2023 was $137.84 Mil.
Cybin's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-50.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cybin EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cybin's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cybin (CYBN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cybin Inc (AMEX:CYBN) » Definitions » EV-to-EBIT
Comparable Companies
TSX:FRX TSX:SVA TSX:ONC NEOE:MMED TSX:EPRX XCNQ:DTC TSXV:NGEN TSX:BCT XCNQ:MSET TSXV:ARCH OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
R7E1:Germany R7E1:Germany CYBN:Canada
Address
100 King Street West, Suite 5600, Toronto, ON, CAN, M5X 1C9
Website
https://www.cybin.com
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds and protocols as potential treatments for various psychiatric and neurological conditions.